Udenyca Administration Information

Udenyca comes in a 6 mg/0.6 ml prefilled syringe. Udenyca is administered subcutaneously, into the fatty layer between the muscle and the skin. It is administered once per chemotherapy cycle after the completion of the chemotherapy regimen. For pediatric patients weighing less than 10 kg, administer 0.1 mg/kg of Udenyca. Administration of less than 0.6 ml is not recommended as it may potentially lead to dosing errors.

Do not administer Udenyca between 14 days before or 24 hours after the administration of cytotoxic chemotherapy.

The carton should be removed from the fridge and left to sit at room temperature for a minimum of 30 minutes prior to injection. Discard any prefilled syringe if left at room temperature for 48 hours or more.

Do not administer Udenyca if there is any discoloration or particulate matter detected in the prefilled syringe.

Avoid use of heat sources (such as tanning beds, heating pads, electric blankets, saunas, and hot tubs). Avoid long, hot baths or sunbathing. Excessive heat may cause your body temperature to rise, potentially causing accelerated metabolism of the drug.

Do not travel, drive, or do other tasks or actions that require alertness during hours 26 through 29 after the injection.